Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al.
Crocus sativus
L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
Phytother Res. 2005;19:148–51.
Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, et al. Hydro-alcoholic extract of
Crocus sativus
L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
J Ethnopharmacol. 2005;97:281–4.
Akhondzadeh S, Fallah-Pour H, Afkham K, et al. Comparison of
Crocus sativus
L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].
BMCComplement Altern Med. 2004;4:12.
Abdullaev Jafarova F, Caballero-Ortega H, Riveron-Negrete L, et al. In vitro evaluation of the chemopreventive potential of saffron [in Spanish].
Rev Invest Clin. 2003;54:430–6.
Escribano J, Alonso GL, Coca-Prados M, et al. Crocin, safranal and picrocrocin from saffron (
Crocus sativus
L.) inhibit the growth of human cancer cells in vitro.
Cancer Lett. 1996;100:23–30.
Abdullaev FI, Espinosa-Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials.
Cancer Detect Prev. 2004;28:426–32.
Molnar J, Szabo D, Pusztai R, et al. Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates.
Anticancer Res. 2000;20:861–7.
Abdullaev FI, Riveron-Negrete L, Caballero-Ortega H, et al. Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (
Crocus sativus
L.).
Toxicol In Vitro. 2003;17:731–6.
Garcia-Olmo DC, Riese HH, Escribano J, et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (
Crocus sativus
L.): an experimental study in the rat.
Nutr Cancer. 2000;35:120–6.
Xu GL, Yu SQ, Gong ZN, et al. Study of the effect of crocin on rat experimental hyperlipemia and the underlying mechanisms [in Chinese].
Zhongguo Zhong Yao Za Zhi. 2005;30:369–72.
el Daly ES. Protective effect of cysteine and vitamin E,
Crocus sativus
and
Nigella sativa
extracts on cisplatin-induced toxicity in rats.
J Pharm Belg. 1998;53:87–93.
Abe K, Saito H. Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation.
Phytother Res. 2000;14:149–52.
Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, et al. Hydro-alcoholic extract of
Crocus sativus
L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
J Ethnopharmacol. 2005;97:281–4.
Moshiri E, Basti AA, Noorbala AA et al. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A double-blind, randomized and placebo-controlled trial.
Phytomedicine. 2006 Sep 14 [Epub ahead of print]
Akhondzadeh Basti A, Moshiri E, Noorbala AA, et al. Comparison of petal of
Crocus sativus L
and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 14 [Epub ahead of print].
Modaghegh MH, Shahabian M, Esmaeili HA, et al. Safety evaluation of saffron (
Crocus sativus) tablets in healthy volunteers.
Phytomedicine.
2008 Aug 5.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.